ESLD

AcronymDefinition
ESLDEnd Stage Liver Disease
ESLDEuropean Society for Laser Dermatology (Bassum, Germany)
References in periodicals archive ?
The highest proportion of LT waitlist registrations for HCV-related ESLD was for persons in the birth cohort and increased incrementally from 61.
Considering that our patient had a low MELD score but an oncologic etiology of her ESLD, she was predisposed to hypercoagulability.
Thirteen ESLD patients requiring liver transplants were evaluated.
This proprietary drug combination is designed to reduce inflammation and increase angiogenesis to restore liver function, potentially extending the life of ESLD patients awaiting liver transplant.
As we move towards long-term care of our patients, the issues pertaining to acute and chronic viral hepatitis co-infections, non-viral liver disease, ESLD and transplantation will continue to demand attention from clinicians and investigators in the field.
Protein restriction and the use of oral or enteral formulas enriched in branched chain amino acids but low in aromatic amino acids are frequently the MNTs chosen in ESLD, however, they are not the most current or effective clinical practice (Krentisky, 2003; Mizock, 1999).
Biliary atresia leading to cirrhosis is by far the most common cause of ESLD in the paediatric population, accounting for over 50% of the indications for LT.
A recent review of several studies in graft recipients and ESLD patients (11) concluded that a MEGX concentration <15-25 [micro]g/L is associated with severe impairment of liver function.
Food and Drug Administration granted Proteonomix permission to conduct a Phase 1 clinical trial with UMK-121 in patients with ESLD.
Food and Drug Administration had granted permission to the Company to initiate a Phase 1 clinical trial to evaluate UMK-121 in patients with ESLD.
Our UMK-121 pharmaceutical therapy is advancing toward clinical trials in ESLD patients," Dr, Ian McNiece, chief scientific officer.
We hope and anticipate that this trial will demonstrate the potential of UMK-121 to mobilize stem cells in order to improve liver function in patients with ESLD.